Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia

Determinants of Statin Initiation Among Adult Diabetic Patients in Bonga, Ethiopia

Bezie Kebede zelalem, Desalegn Feyisa School of Pharmacy, College of Health Science, Mizan-Tepi University, Mizan-Teferi, EthiopiaCorrespondence: Bezie Kebede zelalem Tel +251 921279910Email beza.kebede21@gmail.comBackground: Diabetes mellitus (DM) is a chronic degenerative disease associated with a...

Full description

Bibliographic Details
Main Authors:	Kebede zelalem B, Feyisa D
Format:	Article
Language:	English
Published:	Dove Medical Press 2020-12-01
Series:	Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:	diabetes statin initiation determinants primary prevention secondary prevention general hospital
Online Access:	https://www.dovepress.com/determinants-of-statin-initiation-among-adult-diabetic-patients-in-bon-peer-reviewed-article-DMSO

Similar Items

Statins in primary prevention: is the enthusiasm justified?
by: Arun K. Chopra, et al.
Published: (2020-07-01)

Prescribing pattern of statins for primary prevention of cardiovascular diseases in patients with type 2 diabetes: insights from Ethiopia
by: Gebre Teklemariam Demoz, et al.
Published: (2019-07-01)

An education-behavioural intervention improves adherence to statins
by: Kardas Przemyslaw
Published: (2013-10-01)

Statins in Secondary Prevention of Atrial Fibrillation
by: V. I. Podzolkov, et al.
Published: (2016-11-01)

Adherence to statins and its impact on clinical outcomes: a retrospective population-based study in China
by: Boya Zhao, et al.
Published: (2020-06-01)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly
by: Sydney B Long, et al.
Published: (2010-12-01)

Pattern of statin use changes following media coverage of its side effects
by: Kriegbaum M, et al.
Published: (2017-07-01)

Statins in Healthy Adults: A Meta-Analysis
by: Lee Sandwith, et al.
Published: (2021-06-01)

PRIMARY PREVENTION OF CARDIOVASCULAR COMPLICATIONS: VALUE OF STATINS
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

Correction of Hypercholesterolemia in Primary and Secondary Prevention of Cardiovascular Diseases: Features and Controversial Issues
by: N. M. Akhmedzhanov, et al.
Published: (2019-01-01)

Time trends analysis of statin prescription prevalence, therapy initiation, dose intensity, and utilization from the hospital information system of Jinshan Hospital, Shanghai (2012–2018)
by: Yujuan Liu, et al.
Published: (2020-04-01)

STATIN GENERICS: EFFICACY AND SAFETY RATIO
by: V. P. Voronina, et al.
Published: (2016-01-01)

Impact of combination therapy with statin and ezetimibe on secondary prevention for post-acute myocardial infarction patients in the statin era
by: Soichiro Ebisawa, et al.
Published: (2015-09-01)

New clinical and pharmacological aspects of the use of atorvastatin for primary and secondary prevention of complications of cardiovascular diseases
by: S. R. Gilyarevsky, et al.
Published: (2018-09-01)

Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
by: Thongtang N, et al.
Published: (2020-02-01)

Time trends in statin use and incidence of recurrent cardiovascular events in secondary prevention between 1999 and 2013: a registry-based study
by: Nele Laleman, et al.
Published: (2018-11-01)

Statin drugs to reduce breast cancer recurrence and mortality
by: Colin H. Beckwitt, et al.
Published: (2018-11-01)

Secondary prevention of major cerebrovascular events with seven different statins: a multi-treatment meta-analysis
by: Zhong P, et al.
Published: (2017-08-01)

Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction
by: Yan-Rong Li, et al.
Published: (2017-09-01)

Statins in Females
by: Vanajakshamma Velam, et al.
Published: (2019-05-01)

Clinical effects of statins: focusing on simvastatin
by: D. M. Aronov, et al.
Published: (2009-04-01)

Long-term statin adherence in patients after hospital discharge for new onset of atherosclerotic cardiovascular disease: a population-based study of real world prescriptions in Taiwan
by: Shu-ting Chen, et al.
Published: (2019-03-01)

Primary And Secondary Prevention In Stroke: Approact To Diabetes Mellitus Cases
by: Derya Uludüz, et al.
Published: (2013-04-01)

The correlation of the efficacy and safety of statins with the aim of primary and secondary prevention: myths and reality
by: S R Gilyarevsky, et al.
Published: (2015-06-01)

Analysis of the Dilemma Involving Statins and Aspirin as Primary Prevention Alternatives in Cardiovascular Disease
by: Henry Sutanto
Published: (2017-10-01)

Global variation of risk thresholds for initiating statins for primary prevention of cardiovascular disease: a benefit-harm balance modelling study
by: Henock G. Yebyo, et al.
Published: (2020-09-01)

The Role of Statins in Prevention of Preeclampsia: A Promise for the Future?
by: Vasiliki Katsi, et al.
Published: (2017-05-01)

Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individuals
by: Dong-Hyeon Lee, et al.
Published: (2017-09-01)

STATINES IN PREVENTION AND TREATMENT OF ATHEROSCLEROSIS CONNECTED DISEASES: EFFICIENCY AND SAFETY
by: Y. A. Karpov
Published: (2015-12-01)

Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
by: Kamal Awad, et al.
Published: (2021-06-01)

Aspirin and Statin Use and the Risk of Gallbladder Cancer
by: Kritika Prasai, et al.
Published: (2021-03-01)

National background is associated with disparities in initiation and persistence to statin treatment in patients with diabetes in Denmark
by: Helena eDomínguez, et al.
Published: (2010-12-01)

Statin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United States
by: Mitchell Aaron P, et al.
Published: (2012-07-01)

Prediction and Prevention of Type 1 Diabetes
by: Marina Primavera, et al.
Published: (2020-06-01)

Iranian general populations' and health care providers' preferences for benefits and harms of statin therapy for primary prevention of cardiovascular disease
by: Hassan Saadati, et al.
Published: (2020-11-01)

Television viewing time among statin users and non-users. The Polish Norwegian Study (PONS)
by: Georgeta D. Vaidean, et al.
Published: (2017-09-01)

Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis
by: Irene Tramacere, et al.
Published: (2019-03-01)

Use of statins in primary prevention of coronary artery disease: new data on risk-benefit balance
by: S. R. Gilyarevskiy, et al.
Published: (2013-12-01)

Should statin guidelines consider patient preferences? Eliciting preferences of benefit and harm outcomes of statins for primary prevention of cardiovascular disease in the sub-Saharan African and European contexts
by: Henock G. Yebyo, et al.
Published: (2018-05-01)

Statin Use Decreases the Risk of Metachronous Gastric Cancer in Patients without <i>Helicobacter pylori</i> Infection
by: Tae Jin Kwon, et al.
Published: (2021-03-01)